Abstracts & Informative Case Reports
SUBMISSIONS SITE CLOSED
WHO SHOULD SUBMIT
Abstract and Informative Case Report submission is open to physician-scientists, research scientists, clinicians and medical education professionals. This is a multi-disciplinary meeting; abstract submission is highly recommended for young investigators, fellows, junior scientists and trainees, who will benefit from close interaction with senior colleagues regarding his/her work. You may submit as many abstracts as you like; however only one abstract will be considered for an award.
ONLINE SUBMISSION
Abstracts and Informative Case Reports must be submitted online via the CSCTR / MWAFMR abstract submission site. To ensure your data is entered correctly, follow all instructions carefully. Complete instructions for submission available online. When you completed the abstract submission process, print a copy of your submitted abstract for your files.
Abstract Example Case Report Example
IMPORTANT DATES TO REMEMBER
| Submissions Open | Friday, October 28, 2022 |
|
Early Fee Submission Deadline Members of CSCTR and AFMR: $50.00 per submission |
Friday, January 6, 2023 11:59 pm Central Time |
|
Regular Submission Deadline Members of CSCTR and AFMR: $70.00 per submission |
Monday, February 6, 2023 Extended until |
| Author Result Notifications (all submitters will receive notification regardless of the result) |
Between Monday, March 6, 2023 and Friday, March 10, 2023 |
| Author Accept / Decline Deadline | Wednesday, March 15, 2023 |
NOTES: If your abstract is accepted and you are unable to attend the meeting, please decline the invitation to present. You must attend and present your abstract(s) as assigned to be published in the Journal of Investigative Medicine.
REVIEW
All abstracts submitted will be graded by CSCTR / MWAFMR Midwest Clinical & Translational Research Meeting program committee members. The review process typically takes 2-3 weeks.
SUBMISSION CATEGORIES
Abstract Categories / Informative Case Report Categories
Bio-engineering
Bone Marrow Transplant
Cardiology / Cardiovascular Disease
Dermatology
Diagnosis or Treatment of a Disease Process or Clinical Syndromes
Educational / Outcome Research
Endocrinology / Metabolism
Epidemiology / Health Outcomes / Quality Improvement / Bio-informatics
Gastroenterology / Clinical Nutrition
Genetic and Molecular Medicine
Geriatrics
Health Disparities
Hematology and Oncology
Dissemination/Implementation Science
Infectious Disease
Nephrology
Neurology/Neurodegeneration
Pathophysiology
Pediatrics
Pulmonary / Critical Care
Rheumatology / Immunology / Allergy
Other specialties also welcomed
REPORT LENGTH
There is a limit of 3,800 characters (including spaces) for the text of your abstract or informative case report submission. The character limit does not count authors, institutions, title or table(s).
SUBMISSION FEES
A non-refundable fee will be charged to cover the costs of processing, review, and/or publication. You must include a separate payment with each abstract or informative case report submitted. You will not be able to submit an abstract or informative case report without entering your appropriate payment information. After entering your information a page will appear that you will print as your receipt. The fee schedule is as follows:
| Thru January 6 | Thru February 6 February 13 | |
| Members of CSCTR and AFMR | $50.00 | $70.00 |
| Non-members | $115.00 | $135.00 |
AWARDS
Are you eligible for one or more awards? Visit the awards page for additional information and qualifications. During the abstract submission process you will be asked for which awards you are eligible. You may select all awards for which you are eligible. However, of the awards you are eligible for and you selected in the abstract submission form, only one award will be offered. You are unable to apply for an award after the abstract submission closes.
AUTHOR ATTENDANCE REQUIREMENT
By submitting an abstract or informative case report to the Midwest Clinical & Translational Research Meeting, you agree that at least one author will attend the meeting if the abstract or informative case report is accepted. An author must be available to present on the date and time assigned by the Meeting program committee. Authors will be notified of presentation times at the time of, or shortly after, notification of acceptance and are expected to make appropriate travel arrangements to ensure that at least one author is present.
Only the abstract(s) of presenting authors who attended the meeting will be published in the Journal of Investigative Medicine. Abstract(s) of no show authors will not be published.